Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002104 · ClinicalTrials.gov registry record · Phase 1
Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
A Phase 1 study, sponsored by Aaron Diamond AIDS Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002104 is a Phase 1 study that has completed, run by Aaron Diamond AIDS Research Center.
The verdict
NCT00002104, a Phase 1 study, has completed, sponsored by Aaron Diamond AIDS Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
To demonstrate, in patients with tubercular or nontubercular mycobacterium infections with or without HIV infection, the safety of thalidomide use as judged by symptoms, physical exam, and studies of microbiologic, immunologic, hematologic, renal, and hepatic status. To demonstrate efficacy of the drug as judged by status of fever, nutrition, tuberculosis lesions, and immune responses.
Interventions
- DRUG Thalidomide
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002104
The ClinicalTrials.gov registry entry for NCT00002104 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Aaron Diamond AIDS Research Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thalidomide is the first listed.
NCT00002104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002104 about?
NCT00002104 is a clinical study titled "Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV". To demonstrate, in patients with tubercular or nontubercular mycobacterium infections with or without HIV infection, the safety of thalidomide use as judged by symptoms, physical exam, and studies of microbiologic, immunologic, hematologic, renal, and hepatic status. To demonstrate efficacy of the d...
What is the current status of trial NCT00002104?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00002104?
The interventions under investigation include: Thalidomide (DRUG).
Who is sponsoring clinical trial NCT00002104?
This trial is sponsored by Aaron Diamond AIDS Research Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.